Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial.

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain (2011) 0.95

Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache. Neuropsychiatr Dis Treat (2007) 0.83

Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders. Toxins (Basel) (2015) 0.81

Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial. J Neurol (2007) 0.80

Botulinum toxin in multiple sclerosis. J Neurol (2006) 0.78

Evidence based medicine on the use of botulinum toxin for headache disorders. J Neural Transm (Vienna) (2007) 0.77

Botulinum toxin type a for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial. Neurol Int (2014) 0.77

Botulinum toxin: could it be an effective treatment for chronic tension-type headache? J Headache Pain (2008) 0.75

Headache (chronic tension-type). BMJ Clin Evid (2009) 0.75

Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia (2005) 0.75

Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet (1998) 4.33

Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke (2001) 3.90

Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg (2000) 3.83

Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology (2006) 2.46

SSEPs and prognosis in postanoxic coma: only short or also long latency responses? Neurology (2006) 2.31

Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD) Nephrol Dial Transplant (1999) 2.04

EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol (2006) 1.97

Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry (2001) 1.84

Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology (2008) 1.80

Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology (2007) 1.79

Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet (1999) 1.67

Handicap questionnaires: what do they assess? Disabil Rehabil (1999) 1.60

Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology (2004) 1.58

Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost (1997) 1.56

The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clin Rehabil (1999) 1.51

Psychometric properties of the Impact on Participation and Autonomy Questionnaire. Arch Phys Med Rehabil (2001) 1.50

Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review. Neurology (2002) 1.47

The burden of caregiving in partners of long-term stroke survivors. Stroke (1998) 1.41

Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry (2000) 1.26

Wound healing in cell studies and animal model experiments by Low Level Laser Therapy; were clinical studies justified? a systematic review. Lasers Med Sci (2002) 1.25

What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? J Neurol (2008) 1.21

Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke (1997) 1.21

The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting. Eur J Cancer (2004) 1.18

Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage. Intensive Care Med (2001) 1.17

The role of cognitive impairment in the quality of life after ischaemic stroke. J Neurol (1996) 1.15

Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis (2000) 1.13

The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease. Neurology (2007) 1.12

Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry (2006) 1.09

Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice. Br J Cancer (2003) 1.08

Posttraumatic stress symptoms in adult survivors of childhood cancer. Pediatr Blood Cancer (2004) 1.07

Measuring quality of life in children with inflammatory bowel disease: the impact-II (NL). Qual Life Res (2002) 1.04

Interobserver and intraobserver reproducibility of peripheral blood and oxygen pressure measurements in the assessment of lower extremity arterial disease. J Vasc Surg (2001) 1.01

Interobserver variation in the interpretation of SSEPs in anoxic-ischaemic coma. Clin Neurophysiol (2006) 1.01

Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology (2004) 1.01

Assessment of burden in partners of stroke patients with the sense of competence questionnaire. Stroke (1998) 1.01

Quality of survival after cardiopulmonary resuscitation. Arch Intern Med (1999) 0.98

Comparison of maximal voluntary isometric contraction and hand-held dynamometry in measuring muscle strength of patients with progressive lower motor neuron syndrome. Neuromuscul Disord (2003) 0.98

No excess fatigue in young adult survivors of childhood cancer. Eur J Cancer (2003) 0.97

A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30). Stroke (1997) 0.97

Risk factors for falls of hospitalized stroke patients. Stroke (1997) 0.95

Acute scrotal pain from idiopathic ilioinguinal neuropathy: diagnosis and treatment with EMG-guided nerve block. Clin Neurol Neurosurg (2007) 0.93

Migraine treated with acyclovir. Headache (2005) 0.92

Impact of survival probability, life expectancy, quality of life and patient preferences on do-not-attempt-resuscitation orders in a hospital. Resuscitation Committee. Resuscitation (1999) 0.92

Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscul Disord (2010) 0.92

Efficacy of low-level laser therapy in the management of stage III decubitus ulcers: a prospective, observer-blinded multicentre randomised clinical trial. Lasers Med Sci (2003) 0.92

Direct costs of modern treatment of aneurysmal subarachnoid hemorrhage in the first year after diagnosis. Stroke (2002) 0.91

Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90

Bacterial contamination of ready-to-use 1-L feeding bottles and administration sets in severely compromised intensive care patients. Crit Care Med (2000) 0.89

Patients' satisfaction with care after stroke: relation with characteristics of patients and care. Qual Health Care (1996) 0.88

Decisions to terminate resuscitation. Resuscitation Committee. Resuscitation (1999) 0.88

Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology (2000) 0.87

Clinical meaning of the Stroke-Adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136. Stroke (2000) 0.87

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial. Trials (2010) 0.86

Number of nursing staff and falls: a case-control study on falls by stroke patients in acute-care settings. J Adv Nurs (1993) 0.85

[New therapies in neurology, but who benefits?]. Ned Tijdschr Geneeskd (1999) 0.85

Prognostic factors for ambulation and activities of daily living in the subacute phase after stroke. A systematic review of the literature. Clin Rehabil (2003) 0.84

Prediction of poor outcome in anoxic-ischemic coma. J Clin Neurophysiol (2000) 0.84

Impact of stroke type on survival and functional health. Cerebrovasc Dis (2001) 0.84

Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial. Cerebrovasc Dis (2009) 0.83

Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson's disease: one year follow-up of a randomised observer-blind multi centre trial. Acta Neurochir (Wien) (2006) 0.83

The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatr Hematol Oncol (2002) 0.82

Prognostic factors in the subacute phase after stroke for the future residence after six months to one year. A systematic review of the literature. Clin Rehabil (2003) 0.81

The usefulness of a laser Doppler in the measurement of toe blood pressures. J Vasc Surg (2000) 0.80

Transient global amnesia: a genetic disorder? Eur Neurol (2010) 0.80

Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial. J Neurol (2007) 0.80

Presence and persistence of nutrition-related symptoms during the first year following esophagectomy with gastric tube reconstruction in clinically disease-free patients. World J Surg (2010) 0.80

No indication for patent foramen ovale closure in migraine. Neth Heart J (2009) 0.80

Wiggling ears: an unusual EEG artifact caused by muscle activity. Clin Neurophysiol (2006) 0.79

Clinimetric evaluation of the pain observation scale for young children in children aged between 1 and 4 years after ear, nose, and throat surgery. J Dev Behav Pediatr (1999) 0.79

Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients. J Neurol Neurosurg Psychiatry (2001) 0.79

Treatment outcomes in cervical dystonia: a clinimetric study. Mov Disord (1996) 0.79

The reliability of assessment of vibration sense. Acta Neurol Scand (2003) 0.79

In vivo analysis of end-plate noise of human extensor digitorum brevis muscle after intramuscularly injected botulinum toxin type A. Muscle Nerve (2002) 0.79

Long-term superiority of subthalamic nucleus stimulation over pallidotomy in Parkinson disease. Neurology (2009) 0.78

Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment. J Neurol (2002) 0.78

Improved brief assessment of cognition in aging and dementia. Neurology (2004) 0.76

Reliability of injury grading systems for patients with blunt splenic trauma. Injury (2012) 0.76

[A modified informed-consent procedure in which the complete information is given retrospectively: no objection from participating patients]. Ned Tijdschr Geneeskd (2005) 0.76

The Stroke Unit Discharge Guideline, a prognostic framework for the discharge outcome from the hospital stroke unit. A prospective cohort study. Clin Rehabil (2005) 0.76

PET scanning and neuronal loss in acute vegetative state. PROPAC-Study Group. Lancet (2000) 0.75

[A new instrument to measure clinical outcome]. Ned Tijdschr Geneeskd (2002) 0.75

[Prevention and treatment of osteoporosis]. Ned Tijdschr Geneeskd (1992) 0.75

[The practice guideline 'TIA' (first revision) from the Dutch College of General Practitioners; a response from the perspective of neurology]. Ned Tijdschr Geneeskd (2005) 0.75

The quality of Intensive Care nursing before, during, and after the introduction of nurses without ICU-training. Heart Lung (2003) 0.75

[A meningioma resulting in drastic changes in behavior and life course]. Ned Tijdschr Geneeskd (2006) 0.75

The Critical Nursing Situation Index for safety assessment in intensive care. Intensive Care Med (2001) 0.75

[Guideline development in the Academic Medical Center, Amsterdam, the Netherlands, 1992-2001]. Ned Tijdschr Geneeskd (2003) 0.75

['Migraine and a hole in the heart': causal relationship between migraine and patent foramen ovale not established]. Ned Tijdschr Geneeskd (2006) 0.75

[Coordinating task reserved for transmurally- and extramurally active nurses. The long-term impact of a stroke]. TVZ (1997) 0.75

Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials. Transfus Med (2014) 0.75